Early-Stage DPN Diagnosis

The 128 Hz frequency is the recognized standard in the U.S. for testing peripheral neuropathy, particularly for evaluating vibration perception in large fiber nerve function. Widely endorsed by organizations such as the American Diabetes Association (ADA), CDC. and CMS guidelines, this trusted method forms the foundation for the Electronic Tuning Fork™ (ETF), which enhances and modernizes vibration testing with electronic precision.

The ETF™ is a patented, FDA-registered medical device designed by an American Foot and Ankle Surgeon. It preserves the accuracy and reliability clinicians rely on while overcoming the limitations of traditional tuning forks. By providing objectivity, standardization, and quantifiable results, the ETF™ offers a cutting-edge solution for diagnosing and monitoring neuropathy progression, empowering physicians with advanced tools to improve patient outcomes.

Diabetic Large Nerve Fiber Dysfunction (Painless) as Measured by Vibration Predicts Foot Ulceration, Amputation and Mortality.

https://care.diabetesjournals.org/content/32/10/1896

Why the ETF Matters

Diabetic Peripheral Neuropathy (DPN) is a significant risk factor for diabetic limb loss, often progressing to foot ulcers and lower-extremity amputations if left undiagnosed or untreated. These complications are linked to high mortality rates. While traditional 128 Hz tuning forks have been an invaluable tool for detecting DPN, they lack standardization and the ability to provide measurable results.

The ETF™ overcomes these challenges by offering:

• Objectivity: Eliminates variability in manual testing.

• Standardization: Ensures consistent testing protocols across patients and providers.

• Quantification: Provides measurable data for documenting clinical findings in electronic medical records (EMRs).

The ETF™ allows clinicians to diagnose DPN earlier, enabling the implementation of preventive strategies to reduce limb loss and improve patient outcomes. Its improved accuracy, reproducibility, and ability to provide objective data make it an indispensable tool for modern neurological screening. With the ETF™, physicians can confidently take the next step in patient care, combining the sensitivity of traditional tuning forks with the precision and standardization of cutting-edge technology.